Commentary on Clinical Safety of Recombinant Human Parathyroid Hormone 1-34 in the Treatment of Osteoporosis in Men and Postmenopausal Women

  • Armen H. Tashjian
    Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts, USA
  • Bruce A. Chabner
    Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA

収録刊行物

被引用文献 (7)*注記

もっと見る

問題の指摘

ページトップへ